{
  "query": "Alzheimer",
  "resolved": null,
  "signals": [
    {
      "type": "hot_area",
      "headline": "\"Alzheimer\" heating up — 7 grants ($201,663,621), 36 active trials (15 started <12 mo)",
      "entity": "Alzheimer",
      "ticker": null,
      "upstream": {
        "event": "NIH grant velocity",
        "detail": "7 grants, $201,663,621 in window"
      },
      "observed": {
        "event": "Trial velocity",
        "detail": "36 trials, 15 newly started"
      },
      "predicted": {
        "event": "Elevated M&A / licensing / IPO activity in this mechanism over 12–24 mo",
        "leadTime": "12–24 mo",
        "note": "Funding+trial co-velocity historically precedes BD activity; directional only."
      },
      "leadTime": "12–24 mo to BD/commercial activity (directional)",
      "confidence": 0.5,
      "sponsors": [
        "National Institute of Mental Health (NIMH)",
        "Lighthouse Pharmaceuticals, Inc.",
        "Columbia University",
        "Institute for Molecular Medicine",
        "University of Kansas Medical Center",
        "Arctic Therapeutics",
        "Centre Hospitalier Universitaire de Saint Etienne",
        "First Affiliated Hospital of Zhejiang University"
      ]
    }
  ],
  "recentFilings": null,
  "disclaimer": "Research/informational. NOT investment advice.",
  "generatedAt": "2026-08-05T09:00:27.014Z"
}